Was induction of HIV-1 through TLR9?

Development of an antisense oligonucleotide targeting EFEMP1 in models relevant to macular degeneration.

Molecular therapy. Nucleic acids·2026

Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products.

The AAPS journal·2026

Transient Cyclic Structured Oligonucleotide Designs for Therapeutic Applications.

Current protocols·2026

Developing antisense oligonucleotides for a TECPR2 mutation-induced, ultra-rare neurological disorder using patient-derived cellular models.

Molecular therapy. Nucleic acids·2022

Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors.

Immuno-oncology technology·2022

Introduction and History of the Chemistry of Nucleic Acids Therapeutics.

Methods in molecular biology (Clifton, N.J.)·2022

Age-related changes in the human T cell receptor alpha repertoire suggest positive selection of dual-specific T cells.

Journal of immunology (Baltimore, Md. : 1950)·2026

Recombinant SpTrf proteins illustrate putative functions of native SpTrf proteins: from immune response to resolution in sea urchins.

Journal of immunology (Baltimore, Md. : 1950)·2026

CD55 downregulation identifies a pathogenic CD4+ T cell axis linked to p38 MAPK signaling in rheumatoid arthritis.

Journal of immunology (Baltimore, Md. : 1950)·2026

PD-L1 restrains T-cell immunity in Nile tilapia by suppressing activation-induced fatty acid synthesis.

Journal of immunology (Baltimore, Md. : 1950)·2026

Immunotherapy of malignant melanoma using T cell-activating microbeads.

Journal of immunology (Baltimore, Md. : 1950)·2026

Isotype-specific antibody secreting plasma cells harbor epigenetic and transcription factor architectures defining distinct cell lineages.

Journal of immunology (Baltimore, Md. : 1950)·2026

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Frontiers in oncology·2026

Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

Nature reviews. Cancer·2026

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Clinical rheumatology·2026

Erratum to 'Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer' [JTO Clinical and Research Reports 7 (2026) 101019].

JTO clinical and research reports·2026

Mathematical and Mouse Models Identify Regulatory T Cell Influx as A Key Determinant of Acquired Resistance to PD-1 Immunotherapy.

Cancer research·2026

Peripheral cytokine distinguish recent from Mycobacterium tuberculosis infection and active tuberculosis.

Frontiers in microbiology·2026

Related Experiment Videos

Was induction of HIV-1 through TLR9?

Related Concept Videos

Development of an antisense oligonucleotide targeting EFEMP1 in models relevant to macular degeneration.

Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products.

Transient Cyclic Structured Oligonucleotide Designs for Therapeutic Applications.

Developing antisense oligonucleotides for a TECPR2 mutation-induced, ultra-rare neurological disorder using patient-derived cellular models.

Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptors.

Introduction and History of the Chemistry of Nucleic Acids Therapeutics.

Age-related changes in the human T cell receptor alpha repertoire suggest positive selection of dual-specific T cells.

Recombinant SpTrf proteins illustrate putative functions of native SpTrf proteins: from immune response to resolution in sea urchins.

CD55 downregulation identifies a pathogenic CD4+ T cell axis linked to p38 MAPK signaling in rheumatoid arthritis.

PD-L1 restrains T-cell immunity in Nile tilapia by suppressing activation-induced fatty acid synthesis.

Immunotherapy of malignant melanoma using T cell-activating microbeads.

Isotype-specific antibody secreting plasma cells harbor epigenetic and transcription factor architectures defining distinct cell lineages.

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Erratum to 'Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer' [JTO Clinical and Research Reports 7 (2026) 101019].

Mathematical and Mouse Models Identify Regulatory T Cell Influx as A Key Determinant of Acquired Resistance to PD-1 Immunotherapy.

Peripheral cytokine distinguish recent from Mycobacterium tuberculosis infection and active tuberculosis.

Related Experiment Videos

Was induction of HIV-1 through TLR9?

Related Concept Videos

Related Articles